NanoenTekInc (039860) - Total Liabilities

Latest as of September 2025: ₩5.42 Billion KRW ≈ $3.68 Million USD

Based on the latest financial reports, NanoenTekInc (039860) has total liabilities worth ₩5.42 Billion KRW (≈ $3.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NanoenTekInc strategic investment ratio to see how much of total assets are deployed in long-term investments.

NanoenTekInc - Total Liabilities Trend (2007–2024)

This chart illustrates how NanoenTekInc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 039860 total asset value.

NanoenTekInc Competitors by Total Liabilities

The table below lists competitors of NanoenTekInc ranked by their total liabilities.

Company Country Total Liabilities
ÖKOWORLD AG
XETRA:VVV3
Germany €24.57 Million
Hf Foods Group Inc
NASDAQ:HFFG
USA $348.78 Million
Agrify Corp
NASDAQ:AGFY
USA $103.43 Million
DeviceENG.CO.Ltd
KQ:187870
Korea ₩65.68 Billion
Fast Ejendom
CO:FED
Denmark Dkr924.33 Million
Dongyang E&P Inc
KQ:079960
Korea ₩84.71 Billion
Tradetool Auto Co Ltd
TWO:3685
Taiwan NT$953.14 Million
FELIX Gold Ltd
AU:FXG
Australia AU$1.22 Million

Liability Composition Analysis (2007–2024)

This chart breaks down NanoenTekInc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 039860 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 13.31 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.07 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.07 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NanoenTekInc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NanoenTekInc (2007–2024)

The table below shows the annual total liabilities of NanoenTekInc from 2007 to 2024.

Year Total Liabilities Change
2024-12-31 ₩5.01 Billion
≈ $3.40 Million
+0.54%
2023-12-31 ₩4.99 Billion
≈ $3.38 Million
-11.42%
2022-12-31 ₩5.63 Billion
≈ $3.81 Million
-44.35%
2021-12-31 ₩10.11 Billion
≈ $6.85 Million
+38.01%
2020-12-31 ₩7.33 Billion
≈ $4.97 Million
+30.55%
2019-12-31 ₩5.61 Billion
≈ $3.80 Million
-19.93%
2018-12-31 ₩7.01 Billion
≈ $4.75 Million
-62.38%
2017-12-31 ₩18.64 Billion
≈ $12.63 Million
-7.41%
2016-12-31 ₩20.13 Billion
≈ $13.64 Million
+40.99%
2015-12-31 ₩14.28 Billion
≈ $9.68 Million
+84.03%
2014-12-31 ₩7.76 Billion
≈ $5.26 Million
-63.45%
2013-12-31 ₩21.23 Billion
≈ $14.38 Million
-1.09%
2012-12-31 ₩21.46 Billion
≈ $14.54 Million
+2.68%
2011-12-31 ₩20.90 Billion
≈ $14.16 Million
+193.93%
2007-12-31 ₩7.11 Billion
≈ $4.82 Million
--

About NanoenTekInc

KQ:039860 Korea Scientific & Technical Instruments
Market Cap
$89.44 Million
₩131.97 Billion KRW
Market Cap Rank
#19694 Global
#1005 in Korea
Share Price
₩4110.00
Change (1 day)
+0.74%
52-Week Range
₩3030.00 - ₩7670.00
All Time High
₩14900.00
About

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a resid… Read more